A decade of change

被引:75
作者
Arrowsmith, John
机构
[1] John Arrowsmith is a scientific director at Thomson Reuters,
[2] 77 Hatton Garden,undefined
[3] London EC1N 8JS,undefined
[4] UK. john.arrowsmith@thomsonreuters.com,undefined
关键词
D O I
10.1038/nrd3630
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Data on indicators such as the number and success rate of research and development projects illustrate trends in the pharmaceutical industry over the past decade.
引用
收藏
页码:17 / 18
页数:2
相关论文
共 3 条
[1]  
Lamattina J(2011)The impact of mergers on pharmaceutical R&D Nature Rev. Drug Discov. 10 559-329
[2]  
Slatko J(2010)The future belongs to biologics Med Ad News 16 34-undefined
[3]  
Arrowsmith J(2011)Trial watch: Phase II failures: 2008–2010 Nature Rev. Drug Discov. 10 328-undefined